BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06491914-completion@plaintrial.com
DTSTAMP:20261027T144945Z
DTSTART;VALUE=DATE:20270107
SUMMARY:A Phase 3b\, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Wee
 ks in Adult Participants With Neovascular Age-Related Macular Degeneration
  (nAMD) or Diabetic Macular Edema (DME) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT06491914
URL:https://plaintrial.com/trial/NCT06491914
END:VEVENT
END:VCALENDAR